ELI LILLY AND COMPANY INDIA PRIVATE LIMITED

ELI LILLY AND COMPANY INDIA PRIVATE LIMITED is primarily a manufacturer.

Company Introduction:

ELI LILLY AND COMPANY INDIA PRIVATE LIMITED is the Indian subsidiary of Eli Lilly and Company, a global pharmaceutical leader headquartered in the United States. The company operates as a research-based pharmaceutical enterprise, focusing on the discovery, development, manufacturing, and marketing of innovative medicines.

In India, Eli Lilly is committed to bringing advanced healthcare solutions to patients across various therapeutic areas, including but not limited to diabetes, oncology, immunology, and neuroscience. The company leverages its global expertise and research capabilities to address unmet medical needs and improve patient outcomes in the Indian market.

Its operations encompass clinical research, local manufacturing (though some products might be imported), and the distribution of a wide range of pharmaceutical products. Eli Lilly's presence in India reflects its dedication to advancing healthcare and contributing to the well-being of the Indian population through cutting-edge medical science and ethical business practices.

Here are some of the products manufactured or marketed by Eli Lilly and Company India Private Limited:

* **Diabetes Care:** Humalog (insulin lispro), Trulicity (dulaglutide), Basaglar (insulin glargine)

* **Oncology:** Alimta (pemetrexed), Gemzar (gemcitabine)

* **Osteoporosis:** Forteo (teriparatide)

* **Mental Health:** Olanzapine

* **Erectile Dysfunction:** Cialis (tadalafil)